SCHOLARLY PUBLICATION
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen David Silberstein, Paul K Winner, Dean K. Leonardi, Daniel D. Mikol, Robert A. Lenz
📄 Abstract
The abstract has not yet been added. Use the official source link for the complete publication record.
🔬 Related Research Papers
The Lancet Neurology